Healthcare / Medical Care FacilitiesThailand
$9.45
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 25% · confianza 25%
FCF escenarios
weak_data · normalized FCF $1.6B · quality 76.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
48/100
C
Piotroski
8/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$23.6B
P/E
18.5x
↓EV/EBITDA
7.8x
↓ROE
10.0%
↑Gross Margin
28.3%
↓Debt/Equity
0.07
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-14.1%
FCF CAGR
-28.6%
FCF margin
13.0%
FCF / Net income
1.18x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $11.98B · net income $1.32B · FCF $1.55B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $11.98B | $11.98B | $11.79B | $11.80B | $18.89B |
| Net Income | $1.32B | $1.32B | $1.28B | $1.41B | $3.04B |
| EBITDA | $2.94B | $2.94B | $2.80B | $2.92B | $5.15B |
| EPS | 0.53 | 0.53 | 0.51 | 0.56 | 1.22 |
| Gross Margin | 28.3% | 28.3% | 27.7% | 31.2% | 32.4% |
| Operating Margin | 15.1% | 15.1% | 14.5% | 16.6% | 22.2% |
| Net Margin | 11.0% | 11.0% | 10.9% | 11.9% | 16.1% |
| Balance Sheet | |||||
| Debt/Equity | 0.07 | 0.07 | 0.07 | 0.13 | 0.31 |
| Current Ratio | 1.41 | 1.41 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $1.55B | $1.55B | $1.06B | $3.16B | $4.26B |
| Returns | |||||
| ROE | 10.0% | 10.0% | 9.9% | 11.2% | 24.4% |
| Valuation | |||||
| P/E | 18.53 | 18.53 | 30.24 | 31.66 | 17.30 |
| EV/EBITDA | 7.76 | 7.76 | 13.56 | 14.92 | 10.47 |
| P/B | 1.79 | 1.79 | 2.97 | 3.51 | 4.23 |
| Growth & Yield | |||||
| Revenue Growth | 1.6% | 1.6% | -0.1% | -37.5% | — |
| EPS Growth | 3.9% | 3.9% | -8.9% | -54.1% | — |
| Dividend Yield | 4.8% | 4.8% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
16.5%
EPS terminal req.
$0.84
Spread vs growth
-12.6%
5Y implied EPS CAGR
13.9%
EPS terminal req.
$1.01
Spread vs growth
-9.9%
10Y implied EPS CAGR
11.9%
EPS terminal req.
$1.63
Spread vs growth
-8.0%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-29.7%
Start / end P/E
28.1x → 17.7x
EPS bridge
0.51 → 0.53
Residual
-1.4%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.